ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Clinical Diabetes
Use of Continuous Glucose Monitoring in Non-Intensively Managed Type 2 Diabetes: A Saudi Arabian Consensus
Provisionally accepted- 1Faculty of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
- 2Division of Endocrinology, University of British Columbia, Vancouver, Canada
- 3Prince Sultan Military Medical City, Riyadh, Saudi Arabia
- 4Security Forces Hospital Program, Riyadh, Saudi Arabia
- 5Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 6National Guard Health Affairs, Jeddah, Saudi Arabia
- 7Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia
- 8King Saud University Medical City, Riyadh, Saudi Arabia
- 9Prince Sultan Military Hospital, Madinah, Saudi Arabia
- 10Imam Abdulrahman Bin Faisal University College of Medicine, Dammam, Saudi Arabia
- 11Alhada Armed Forces Hospital, Taif, Saudi Arabia
- 12King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
- 13King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
- 14Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Saudi Arabia has one of the highest prevalences of diabetes globally, with 16.4% of the population living with type 2 diabetes (T2D). While continuous glucose monitoring (CGM) is widely used for patients with type 1 diabetes, evidence suggests its benefits can extend to patients with T2D. The aim of this Delphi consensus was to provide a framework for the use of CGM in patients with T2D who are non-intensively managed in Saudi Arabia. Methods An expert panel of ten adult endocrinology physicians, one internal medicine and diabetology specialist, and one family medicine physician was formed. Consensus generation was undertaken using Delphi methodology; a face-to-face expert meeting and literature review formed the basis of preliminary statements, which were further refined by the panel. Two rounds of voting were used to confirm the level of agreement to each statement. Results Consensus was reached on 27 statements relating to the use of CGM in non-intensively managed T2D. Recommended patient profiles for continuous and intermittent use of CGM are provided, alongside general principles of CGM use and background statements. Conclusions This consensus provides recommendations and summarizes local and international evidence as well as expert opinion regarding CGM use in patients with T2D. To expand the use of CGM into the wider population of T2D in Saudi Arabia and enable these individuals to benefit from the technology, a shift in healthcare services, education, and attitudes across the country is necessary.
Keywords: Continuous glucose monitoring, Non-intensive, Oralantidiabetics, Saudi Arabia, type 2 diabetes
Received: 03 Nov 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Almehthel, Al-Saeed, Al-Sabaan, Al-Malky, Zarif, Al-Zubaidi, Al-Sofiani, Abdulaal, Al Argan, Alsifri, Al-Harbi and Aldahash. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mohamed Almehthel
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
